Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Clinical trial NCT00113113 · COMPLETED
Trial details
- NCT number
- NCT00113113
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.